We previously reported that high levels of tyrosine kinase receptor (RTK) gene amplification of EGFR, HER2, FGFR2, or MET had protein overexpression and rarely showed other coexisting gene alterations using the next-generation sequencing (NGS) method for gastric cancer [50]. The gene discussed is MET; the disease is gastric cancer.